NCT01344460View on ClinicalTrials.gov

Gadobutrol Enhanced MRA of the Renal Arteries

PHASE3CompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Renal Artery Obstruction
Interventions
DRUG

Gadobutrol (Gadovist, BAY86-4875)

a single bolus injection of approx. 0.1mmol/kg

Trial Locations (70)

116

Taipei

333

Taoyuan District

1090

Vienna

2700

Wiener Neustadt

4031

Basel

4600

Olten

6020

Innsbruck

8091

Zurich

11217

Taipei

12351

Berlin

12808

Prague

21287

Baltimore

23538

Lübeck

24105

Kiel

27710

Durham

31406

Savannah

32209

Jacksonville

33136

Miami

34098

Istanbul

38104

Memphis

38700

La Tronche

48145

Münster

53215

Milwaukee

53705

Madison

54500

Vandœuvre-lès-Nancy

60596

Frankfurt am Main

60611

Chicago

75651

Paris

75877

Paris

75908

Paris

76031

Rouen

76133

Karlsruhe

81346

Kaoshiung

85711

Tucson

90033

Los Angeles

90095

Los Angeles

92660

Orange

02903-4900

Providence

78229-3900

San Antonio

B1846DWA

Adrogué

C1425BEE

Buenos Aires

S2000DTC

Rosario

22281-100

Rio de Janeiro

90035-001

Porto Alegre

04023-061

São Paulo

05403-000

São Paulo

05403-900

São Paulo

05651-901

São Paulo

Unknown

Medellín

Barranquilla

Santiago de Cali

Bogotá

Seoul

Taipei

Istanbul

625 00

Brno

775 20

Olomouc

304 60

Pilsen

150 30

Prague

07740

Jena

31-02

Krakow

90-153

Lodz

20-090

Lublin

02-097

Warsaw

110-744

Seoul

135-720

Seoul

135-710

Seoul

443-721

Suwon

CH-3010

Bern

06500

Ankara

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY